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Background/aim: Sepsis-associated encephalopathy (SAE) is a severe complication of sepsis that affects upwards of half of all sepsis
patients. Few studies have examined the etiology and risk factors of SAE among elderly patients. This study was designed to explore the
epidemiology of SAE and the risk factors associated with its development in elderly populations.
Materials and methods: This was a retrospective analysis of elderly sepsis patients admitted to our intensive care unit between January
2017 and January 2022. We then compared non-SAE and SAE groups concerning baseline clinicopathological findings, underlying
diseases, infection site, disease type, disease severity, biochemical findings, and 28-day mortality. We further stratified patients in the
SAE group based on whether or not they survived for 28 days, and we compared the above data between these groups.
Results: Of the 222 elderly sepsis patients, 132 (59.46%) had SAE. SAE patients were found to be significantly older than non-SAE
patients. Both age and blood sodium concentrations were found to be associated with SAE risk, while elderly sepsis patients without
underlying chronic obstructive pulmonary disease (COPD) have a relatively higher risk of developing SAE. The SAE group also had a
significantly higher rate of 28-day mortality, and sequential organ failure assessment (SOFA) scores were a risk factor associated with
28-day mortality.
Conclusion: Among elderly sepsis patients, SAE risk increases with advancing age, higher blood sodium concentrations, and without
underlying COPD. SAE incidence is associated with a poorer prognosis, and SOFA scores are independent predictors of increased
mortality among elderly SAE patients.
Key words: Sepsis-associated encephalopathy, sequential organ failure assessment scores, acute physiology and chronic health evaluation

1. Introduction
Sepsis, defined as life-threatening organ dysfunction
caused by a dysregulated host response to infection, affects
millions of people worldwide each year and is a leading
cause of global health loss [1, 2]. Over 70% of sepsis
patients suffer from sepsis-associated encephalopathy
(SAE) [3], resulting in severe symptoms including
confusion, delirium, severe cognitive impairment, or
potentially coma [4]. SAE may manifest before other
sepsis symptoms [5]. Significantly, SAE can be associated
with a dramatically poorer patient prognosis [6-8], and
SAE has been considered the ultimate and critical cause
of death for prolonged hospitalization [9]. Surviving SAE
patients are likely to suffer from prolonged or permanent
side effects, including anxiety, depression, dementia,
reduced health-related quality of life, or suicidal behavior

[10]. Despite its severity, the pathophysiological basis of
SAE remains incompletely understood [11]. It is thought
to be attributable, at least in part, to mechanisms including
excessive microglial activation, impaired endothelial
barrier function, and blood-brain barrier (BBB)
dysfunction [4]. Given the relatively limited understanding
of this condition, it is vital that further studies exploring
the risk factors associated with SAE incidence and patient
death be conducted.
Average population age values are rapidly rising in
more developed nations such that elderly individuals
account for >20% of the total population in some areas at
present, and the majority of people outside of the Middle
East and Africa will be 65 years of age or older by 2050
[12]. Advanced age is associated with an increased risk
of sepsis [13] and higher mortality rates among those
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suffering from sepsis [14]. Elderly people >65 years old
account for ~60% of all sepsis cases and ~80% of all sepsisassociated death [15], suggesting that SAE is also likely to
manifest more often among individuals of more advanced
age. Consistent with this possibility, SAE is not frequently
observed among younger individuals despite being
detected more frequently in the general population [16].
There is thus a need for further study of SAE incidence
among the elderly.
Few studies have described the epidemiological
basis for or risk factors associated with SAE incidence
among the elderly. Previous studies have demonstrated a
high incidence of SAE, which was a risk factor for poor
prognosis [17], even when different sepsis diagnostic
criteria are applied (sepsis 1.0 or sepsis 3.0) [18]. The
SOFA scores were independent risk factors for predicting
the occurrence and adverse outcome of SAE [17]. In
addition to the severity of the condition, serum sodium
was related to the presence of SAE [7, 8]. Delirium is one
of the SAE manifestations, and age ≥ 65 years is a risk
factor for sepsis-associated delirium (SAD) [19]. The risk
factors for SAD increase as the severity of the condition
for patients with sepsis increases [19]. Given the condition
mentioned above, we hypothesized that the incidence of
SAE is high among elderly sepsis patients, and there is a
correlation between serum sodium and the occurrence of
SAE, with SOFA scores being independent predictors of
increased mortality among elderly SAE patients. To test
this hypothesis, this retrospective study was designed to
explore differences in clinical findings between elderly
sepsis patients with and without SAE to understand better
the etiology and risk factors of this disease among older
adults.
2. Materials and methods
This study was conducted by the ethics committee
of Hangzhou First People’s Hospital. Related patient
information has been treated anonymously to protect
patient privacy. We waived the requirement for informed
consent because of the study’s retrospective nature. We
followed our team’s primary methods of previous related
research [17].
2.1. Patient selection
This retrospective analysis of all elderly people diagnosed
with sepsis and admitted to our ICU between January
2017 and January 2022. Patient inclusion criteria were
as follows: (1) Patients were diagnosed with sepsis
based upon the sepsis 3.0 definition, which refers to
the life-threatening multiple organ dysfunction caused
by infection, and the multiple organ dysfunction was
determined by an increase of at least 2 points in the
Sequential Organ Failure Assessment score (SOFA
score). (2) Patients were ≥60 years old, consistent with
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the World Health Organization definition of elderly
age in developing nations. (3) Identification of SAE:
Diagnosis of SAE is primarily based upon clinical
presentation presently [20]. Concerning previous studies
[8, 21], SAE was defined at ICU admission as a Glasgow
coma scale (GCS) score of <15 or manifestations of
delirium (including decreased psychomotor activity,
disorientation, inattention, altered thinking, and
agitation) confirmed by the Confusion Assessment
Method for the Intensive Care Unit (CAM-ICU) in this
article [8, 21]. GCS scores and CAM-ICU were evaluated
on the 1st day of sepsis. We used GCS scores and
CAM-ICU measured after temporary sedative/relaxant
medication withdrawal for sedated patients at ICU
admission. Patients admitted to the ICU due to acute
brain dysfunction were excluded (e.g., encephalitis,
meningitis, acute cerebral stroke, status epilepticus,
hypertensive encephalopathy, metabolic encephalopathy,
toxicosis, or traumatic brain injury). We identified 222
sepsis patients meeting these criteria, and they were
separated into SAE and non-SAE groups.
2.2. Data collection
For each of the 222 patients included in this study,
we collected the following data within 24 h of ICU
admission: general clinical findings, Acute Physiology
and Chronic Health Evaluation II (APACHE II) score,
SOFA score, site of infection, hematological findings
(white blood cell (WBC) count, platelet count (PLT),
hematocrit (HCT), biochemical findings (serum sodium
(Na), procalcitonin (PCT), and serum creatinine (Cr)
levels), etiological information, and outcome indicators
(days of hospitalization, 28-day mortality). Telephonebased follow-up was conducted after 28 days, and patient
survival at this time point was used to stratify patients for
analyses of survival-related risk factors.
2.3. Statistical analysis
All data were analyzed using SPSS 22.0 (SPSS Inc, NY,
USA). Categorical and continuous variables are given
as numbers (percentages) and medians [25th–75th
percentiles], respectively, and were compared via the
Mann–Whitney U tests, χ2 tests, or the Fisher’s exact tests,
as appropriate. SAE-associated risk factors were identified
via multivariate logistic regression analysis. Kaplan–Meier
curves were analyzed with the log-rank test. p < 0.05 was
the significance threshold.
3. Results
3.1. Baseline characteristics
During the study period, a total of 191 patients with sepsis
were excluded from this study based on the inclusion
mentioned above and exclusion criteria, yielding a
cohort of 222 elderly sepsis patients admitted to our ICU
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Total sepsis patients
(n=413)
From 1st JAN 2017-1st JAN 2022

Excluded (n=113): Age< 60 years old

Inclusion of Sepsis patients
(n=300)

Excluded (n=78):
Sedative-related cognitive effects (n=36)

Central nervous system infection (n = 9)
Acute cerebrovascular disease (n = 25)
Metabolic encephalopathy (n = 8)
Inclusion of elderly SAE patients
(n=222)

28-day Survival
（n=60)

SAE group

non-SAE group

(n=132)

(n=90)

28-day non-survival
（n=72)

Figure 1. Flowchart of enrolled study participants. SAE = sepsis-associated
encephalopathy.
Figure 1. Flowchart of enrolled study participants. SAE = sepsis associated encephalopathy

(Figure 1). Of these patients, 132 (59.46%; 87 males) were
diagnosed with SAE, and 90 (68 males) were not, and
192/222 (86.5%) were admitted to ICU due to medical
disease. However, no significant differences were observed
in disease types between SAE and non-SAE patients (p
= 0.910). Among SAE individuals, 21/132 (15.91%) had
delirium with a score on the GCS of 15. Coma was the most
common manifestation of SAE in this study, and 29/132
(21.97%) had a score on the GCS of 13–14, 40/132 (30.3%)
had a score on the GCS of 9–12, and 42/132 (31.82%) had
a score on the GCS of 3–8. Additionally, seizures (n =
3/132, 2.27%) and neurological deficits (n = 1/132, 0.76%)
were rarely observed. The median ages of the SAE and
non-SAE groups were 77 [69, 83.75] and 73.5 [65, 81.0]
years, respectively, with SAE patients being significantly
older than non-SAE patients (p = 0.012). We also detected
significant differences between these two groups for SOFA
scores, APACHE II scores, and incidence of underlying
diseases, including stroke, chronic obstructive pulmonary
disease (COPD), and coronary heart disease (CHD) (All p
< 0.05; Table 1).

3.2. Comparison of clinical and etiological findings
between SAE and non-SAE patients
SAE patients had significantly higher infections in the
respiratory tract (p = 0.028) and blood (p = 0.005) relative
to non-SAE patients. In addition, these SAE patients had
higher serum sodium concentrations (p = 0.006) and lower
HCT values (p = 0.003) and platelet counts (p = 0.015)
relative to their non-SAE counterparts. No significant
differences were observed between groups for causative
pathogens or infections of other tissues (p > 0.05; Table 2).
3.3. Comparison of primary outcomes between SAE and
non-SAE patients
Duration of hospitalization and 28-day mortality was
the primary outcomes monitored in our analyses. We
observed no significant differences in hospitalization
duration between the SAE and non-SAE groups. In
contrast, however, we found that the 28-day mortality rate
of SAE patients was significantly higher than that of nonSAE patients (54.5% vs. 28.9%, p < 0.001) (Table 2).
A Kaplan–Meier survival analysis further confirmed
that SAE diagnosis was associated with significantly poorer
28-day survival among elderly sepsis patients (Figure 2;
HR = 1.720, 95% CI: 1.128–2.624; p = 0.012).
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Table 1. Patients’ baseline characteristics.

Variable

All patients
n = 222

SAE
n = 132

Non-SAE
n = 90

p-value

Age, years

76[68，82]

77[69,83.75]

73.5[65，81.0]

0.012

male

155 (69.8)

87 (65.9)

68 (75.6)

female

67 (30.2)

45 (34.1)

22 (24.4)

Medical disease,

192 (86.5)

115 (87.1)

77 (85.6)

Emergency surgery

17 (7.7)

10 (7.6)

7 (7.8)

Elective surgery

13 (5.9)

7 (5.3)

6 (6.7)

Hypertension

128 (57.7)

76 (57.6)

52 (57.8)

0.976

Diabetes

60 (27.0)

38 (28.8)

22 (24.4)

0.474

Coronary heart disease

61 (27.5)

44 (33.3)

17 (18.9)

0.018

Arrhythmia

44 (19.8)

31 (23.5)

13 (14.4)

0.097

COPD

47 (21.2)

22 (16.7)

25 (27.8)

0.047

Chronic liver disease

12 (5.4)

6 (4.5)

6 (6.7)

0.553*

Chronic kidney disease

13 (5.9)

6 (4.5)

7 (7.8)

0.314

Malignant tumor

53 (23.9)

31 (23.5)

22 (24.4)

0.869

Stroke

63 (28.4)

44 (33.3)

19 (21.1)

0.047

SOFA

7 [4，11]

10 [6，13]

4 [2，7]

<0.001**

APACHE II

17 [12，27]

23 [15，31]

12 [9，17]

<0.001**

Sex
0.124

Disease type
0.910

Underlying diseases

Disease severity

COPD: chronic obstructive pulmonary disease; SOFA: sequential organ failure assessment; APACHE II: Acute Physiology, Age and
Chronic Health Evaluation II; *: Statistical analysis using Fisher’s exact probability method; **: Statistical analysis using the Mann–
Whitney test. Chi-squared test was used for statistical treatment of p-values without “*” or “**” annotation.

3.4. Identification of SAE risk factors in the elderly
After adjusting for baseline characteristics, clinical
manifestations and etiological findings, a subsequent
multivariate analysis revealed that both age (OR = 1.054,
95% CI: 1.019–1.089, p = 0.002) and blood sodium
concentration (OR per 1-mmol/L increment = 1.067, 95%
CI: 1.023–1.113, p = 0.004) were independently associated
with SAE risk among elderly sepsis patients, while elderly
sepsis patients without a history of COPD (OR = 2.736,
95% CI: 1.338–5.597, p = 0.006) have a relatively higher
risk of developing encephalopathy (Table 3).
3.5. Identification of mortality-related factors in elderly
SAE patients
Lastly, we separated the 132 elderly SAE patients in our
study cohort into two groups based on whether or not
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they were alive after 28 days (Table 4). The diagnosis of
these patients includes severe pneumonia, abdominal
infections, urinary tract infections, severe cholangitis,
blood diseases, and skin soft-tissue infection. This yielded
two populations: a group of nonsurvival patients (n = 72;
41 males; mean age = 77.68 ± 9.07 years) and a group of
surviving patients (n = 60; 46 males; mean age = 75.67 ±
9.18 years). Overall mortality among SAE patients was
54.5%, with the males being higher in the nonsurvival
group than the percentage of the females (56.9% vs. 43.1%;
p = 0.017). We found that PCT level was significantly higher
among nonsurviving patients (4.31 [1.6, 17.01] vs. 2.34
[0.51, 11.32], p = 0.049), as were mean SOFA scores (10.72
± 3.82 vs. 8.33 ± 4.12, p < 0.001), whereas the percentage
of patients with underlying COPD was significantly lower
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Table 2. Comparison of clinical and etiological findings and primary outcomes in elderly sepsis patients.
All patients
n = 222

SAE
n = 132

Non-SAE
n = 90

p-value

Respiratory tract

163 (73.4)

104 (78.8)

59 (65.6)

0.028

Gastrointestinal tract

12 (5.4)

10 (7.6)

2 (2.2)

0.129*

Biliary tract

24 (10.8)

12 (9.1)

12 (13.3)

0.318

Intraabdominal

34 (15.3)

18 (13.6)

16 (17.8)

0.400

Urinary tract

34 (15.3)

24 (18.2)

10 (11.1)

0.151

Bloodstream infection

19 (8.6)

17 (12.9)

2 (2.2)

0.005

Skin and soft tissue

10 (4.5)

4 (3.0)

6 (6.7)

0.200

Staphylococcus

35 (15.8)

22 (16.7)

13 (14.4)

0.656

Enterococcus

17 (7.7)

9 (6.82)

8 (8.9)

0.569

Escherichia coli

25 (11.3)

14 (10.6)

11 (12.2)

0.708

Acinetobacter baumannii

60 (27.0)

40 (30.3)

23 (25.6)

0.441

Pseudomonas aeruginosa

22 (9.9)

14 (10.6)

8 (8.9)

0.674

Stenotrophomonas maltophilia

14 (6.3)

9 (6.82)

5 (5.6)

0.704

Klebsiella pneumoniae

39 (17.6)

22 (16.7)

17 (18.9)

0.669

Burkholderia cepacia

10 (4.5)

5 (3.8)

5 (5.6)

0.531*

Serratia marcescens

5 (2.3)

4 (3.0)

1 (1.1)

0.651*

Fungus

43 (19.4)

27 (20.5)

16 (17.8)

0.620

WBC (*109/L)

11.10[7.33，15.83]

10.76[7.65，5.32]

11.78 [7.05，16.00]

0.922**

PCT (ng/mL)

3.43[1.01，13.79]

3.72[0.99，14.56]

2.89 [1.04，12.96]

0.491**

PLT (*109/L)

122 [59.5，183]

100[52.25，174]

151[76.5，206]

0.015**

HCT (%)

29.11[24.5，34.03]

29.11[22.8，32.25]

30.95[26.58，34.85]

0.003**

Na (mmol/L)

140[136，145]

141[136.7，146]

139.4[135，141]

0.006**

Cr (umol/L)

84 [60.93，135.2]

83.4 [60.1，134.6]

85.5[68.25，136.2]

0.719**

19.73 [12.75，25]

19.73 [10.25，26]

21.5 [14，23.54]

0.336**

19.73 [12.75，25]

19.73 [10.25，26]

21.5 [14，23.54]

0.336**

98 (44.1)

72 (54.5)

26 (28.9)

<0.001

Variable
Infection source (%)

Main microorganisms, n (%)

Biochemical indicators

Primary outcomes
Duration of hospitalization
Duration of hospitalization in
survival patients
28-day mortality (%)

WBC: white blood cell; PCT: procalcitonin; PLT: blood platelet; HCT: red blood cell specific volume; Na: serum sodium levels; Cr:
Serum creatinine. *: Statistical analysis using Fisher’s exact probability method; **: Statistical analysis using the Mann–Whitney test.
Chi-squared test was used for statistical treatment of p-values without “*” or “**” annotation.

than that among surviving patients (13.9% vs. 20%; p =
0.008). No other significant differences in measured
parameters were observed between these groups (p >
0.05) (Table 4). After adjusting for potential confounders,

a multivariate analysis revealed that only SOFA scores
were independently associated with 28-day mortality in
elderly SAE patients (OR = 1.185, 95% CI: 1.074–1.307, p
= 0.001) (Table 5).
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Figure 2. Kaplan–Meier analysis of the survival of sepsis
patients over 28 days. The SAE and non-SAE patient
groups were compared, revealing that the SAE group
had a significantly high rate of 28-day mortality than
the non-SAE group (HR = 1.720, 95% CI: 1.128–2.624,
p = 0.012).

Table 3. Subsequent multivariate analysis of SAE risk factors in the elderly.
Value

OR

95% CI

p-value

Age

1.054

1.019~1.089

0.002

Without a history of COPD

2.736

1.338~5.597

0.006

Na (per 1-mmol/L increment)

1.067

1.023~1.113

0.004

COPD: chronic obstructive pulmonary disease; Na: serum sodium levels.

4. Discussion
Our retrospective study indicates that over half of elderly
sepsis patients suffer from SAE and were found to be
significantly older than non-SAE patients. In this study, we
found that blood sodium concentrations were associated
with SAE risk independently, while elderly sepsis patients
without underlying chronic obstructive pulmonary disease
(COPD) have a relatively higher risk of developing SAE.
This study confirms our hypothesis that SAE incidence
is associated with a poorer prognosis, and SOFA scores
are independent predictors of increased mortality among
elderly SAE patients.
Sepsis patients admitted to our ICU were divided into
three groups: those with internal disease, those undergoing
emergency surgery, and those undergoing elective surgery.
Consistent with Zhang et al. [7], we found that elderly
sepsis patients primarily suffered from internal disease,
with no significant SAE-related differences in disease
types. However, a previous sizeable multicenter study
found that SAE was more likely to occur in sepsis patients
suffering from internal diseases [8]. Our failure to resolve
any significant differences concerning disease etiology
in the present study may be attributable to our relatively
small sample size. Therefore, future large-scale studies or
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metaanalyses are warranted to explore better how SAE
incidence is related to disease type.
BBB dysfunction can arise in older adults as a result
of many conditions, including hypertension [22], epilepsy
[23], and stroke [24]. We assessed the incidence of these
underlying conditions in elderly sepsis patients, revealing
that SAE patients were more likely to have suffered from
CHD and stroke than were non-SAE patients. However,
whether this relationship is causal remains to be further
studied. There were no significant differences concerning
SAE incidence in elderly individuals due to underlying
hypertension, diabetes, arrhythmia, chronic liver disease,
chronic kidney disease, or malignant tumors. Interestingly,
in our study, elderly SAE patients had a lower frequency of
underlying COPD than those without SAE. Prior studies
have not detected a correlation between basal complicated
COPD and SAE incidence [7, 8]. COPD is believed to be
associated with hypercapnia, and Albayrak et al. found
that total cerebral blood flow volumes were significantly
higher in COPD patients and hypercapnic ones [25].
Thus, we guess that the increase in cerebral blood flow in
COPD patients might improve cerebral perfusion and lead
to a lower risk of SAE. Further prospective studies will,
therefore, be needed to disentangle better the relationship
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Table 4. Baseline characteristics in SAE patients.

Variable

All patients
n = 132

Nonsurvival
n = 72

Survival
n = 60

p-value

Age, years

77[69，83.75]

77.68±9.07

75.67±9.18

0.209

male

87(65.9)

41(56.9)

46(76.7)

female

45(34.1)

31(43.1)

14(23.3)

Medical disease,

115(87.1)

64(88.8)

51(85)

Emergency surgery

10(7.6)

4(5.6)

6(10)

Elective surgery

7(5.3)

4(5.6)

3(5)

Hypertension

76(57.6)

43(59.7)

33(55)

0.585

Diabetes

38(28.8)

23(31.9)

15(25)

0.380

Coronary heart disease

44(33.3)

23(31.9)

21(35)

0.711

Arrhythmia

31(23.5)

17(23.6)

14(23.3)

0.970

COPD

22(16.7)

10(13.9)

12(20)

0.008

Chronic liver disease

6(4.5)

3(4.2)

3(5)

1.000*

Chronic kidney disease

6(4.5)

4(5.6)

2(3.3)

0.688*

Malignant tumor

31(23.5)

14(19.4)

17(28.3)

0.230

Stroke

44(33.3)

22(30.6)

22(36.7)

0.458

SOFA

10 [6，13]

10.72±3.82

8.33±4.12

<0.001

APACHE II

23 [15，31]

24 [18.25，30]

19[13，31]

0.077**

Respiratory tract

104(78.8)

60(83.3)

44(73.3)

0.162

Gastrointestinal tract

10(7.6)

4(5.6)

6(10)

0.511*

Biliary tract

12(9.1)

9(12.5)

3(5)

0.136

Intraabdominal

18(13.6)

9(12.5)

9(15)

0.677

Urinary tract

24(18.2)

12(16.7)

12(20)

0.621

Bloodstream infection

17(12.9)

7(9.7)

10(16.7)

0.236

Skin and soft tissue

4(3.0)

1(1.4)

3(5)

0.329*

Staphylococcus

22(16.7)

16(22.2)

6(10)

0.061

Enterococcus

9(6.82)

7(9.7)

2(3.3)

0.181*

Escherichia coli

14(10.6)

8(11.1)

6(10)

0.837

Acinetobacter baumannii

40(30.3)

26(36.1)

14(23.3)

0.112

Pseudomonas aeruginosa

14(10.6)

9(12.5)

5(8.3)

0.439

Stenotrophomonas maltophilia

9(6.82)

4(5.6)

5(8.3)

1.000*

Klebsiella pneumoniae

22(16.7)

10(13.9)

12(20)

0.348

Burkholderia cepacia

5(3.8)

3(4.2)

2(3.3)

1.000*

Serratia marcescens

4(3.0)

1(1.4)

3(5)

0.329*

Sex
0.017

Disease type
0.628

Underlying diseases

Disease severity

Infection source (%)

Main microorganisms, n (%)
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Table 4. (Continued).
Fungus

27(20.5)

11(15.3)

16(26.7)

0.106

WBC (*109/L)

10.76[7.65，5.32]

11.1[8.85，17.47]

9.95[6.92，14.91]

0.081**

PCT (ng/mL)

3.72[0.99，14.56]

4.31[1.6，17.01]

2.34[0.51，11.32]

0.049**

PLT (*109/L)

100[52.25，174]

96[49.25，163.8]

131[56.5，190]

0.222**

HCT (%)

29.11[22.8，32.25]

29.35[22.73，40.28]

25.55[23.15，31.78]

0.066**

Na (mmol/L)

141[136.7，146]

142[137.4，145.1]

140.1[136.3，147.7]

0.998**

Cr (umol/L)

83.4 [60.1，134.6]

83.9[60.18，124.4]

81.5 [60.1，150]

0.798**

Biochemical indicators

COPD: chronic obstructive pulmonary disease; SOFA: sequential organ failure assessment; APACHE II: Acute Physiology, Age and
Chronic Health Evaluation II; WBC: white blood cell; PCT: procalcitonin; PLT: blood platelet; HCT: red blood cell specific volume; Na:
serum sodium levels; Cr: Serum creatinine. *: Statistical analysis using Fisher’s exact probability method; **: Statistical analysis using the
Mann–Whitney test. Chi-squared test was used for statistical treatment of p-values without “*” or “**” annotation.

Table 5. Multivariate analysis of 28-day mortality in elderly SAE patients.
Value

OR

95% CI

p-value

SOFA

1.185

1.074~1.307

0.001

SOFA: sequential organ failure assessment.

between COPD, arterial blood carbon dioxide partial
pressure, and SAE. In a univariate analysis, we also found
that SAE incidence was higher among elderly sepsis
patients with higher SOFA and APACHE II scores. Note
that GCS scores of < 15 were used to diagnose patients
with SAE; however, GCS scores are a component of SOFA
and APACHE II scores. Patients with higher SOFA and
APACHE II scores are more likely to have SAE, potentially
biasing this conclusion.
Recent multicenter studies have suggested that
Staphylococcus aureus infection is associated with higher
SAE incidence, whereas the source or spread of the
infection is not [8]. However, our study did not detect any
relationship between pathogen type and SAE incidence.
Instead, we found that SAE incidence was associated
with blood or respiratory tract infections. Respiratory
tract infections are the most common source of infection
in patients with sepsis, including the elderly population.
Specifically, 33% of sepsis cases were due to respiratory
tract infections, and 32% to genitourinary infections
[26]. Few studies have explored the relationship between
respiratory tract infections and SAE. As one of the SAE
manifestations, delirium symptoms independently predict
1-year mortality in patients with severe pneumonia
[27]. Interestingly, delirium may also represent the
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phenomenological symptom of inadequate oxygenation
of vital tissues [28], while respiratory tract infections may
impact oxygen delivery, considering that oxygenation
is one of the primary roles of the respiratory system.
Metabolic disorders have also been related to SAE risk
[8]. We found higher serum sodium, lower PLT, and
lower HCT values associated with increased SAE risk in
univariate analysis, with only elevated serum sodium levels
remaining associated with SAE incidence independently
in subsequent multivariate analysis. Hypernatremia is
linked to multiple neurological manifestations, including
encephalopathy, seizures, delirium, and related alterations
in consciousness [29, 30]. Hypernatremia is also
independently associated with delirium and mortality
among patients admitted to the ICU [31]. We could not
further explore this potential relationship between sodium
levels and SAE incidence in our elderly population. We
also found that SAE incidence was not associated with
an increase in hospitalization duration, although it was
associated with significantly reduced 28-day survival, with
higher SOFA scores being independently associated with
the risk of mortality. We speculated that increased disease
severity is associated with poorer patient outcomes.
Given the steadily increasing average age of many
nations, our study offers a clear advantage by focusing
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specifically on SAE incidence among elderly sepsis patients.
Few studies to date have explored the epidemiology of
SAE in elderly populations to understand the risk factors
underlying the incidence of this condition. Our study offers
new data in support of these previous studies. However,
there are several limitations to the present analysis. For
one, this was a retrospective case-control study. Therefore,
future prospective studies will be required to establish any
causal relationships between the risk factors identified
herein and SAE incidence among elderly sepsis patients.
The limited sample size of this study also constrains
our statistical power, potentially leading to inaccurate
conclusions in some contexts. Furthermore, there are
no widely accepted diagnostic criteria for SAE, and the
criteria used in the present study were subjective diagnostic
methods such as GCS scores, CAM-ICU, and defined
exclusion criteria. Therefore, it will be essential to identify
SAE based on other objective criteria in future analyses,
including EEG and somatosensory evoked potentials. Our
analyses also focused explicitly on parameters of interest
in sepsis patients at the time of diagnosis, and as such,
they do not offer any insight into the dynamics of these
parameters over time since they pertain to SAE risk.
In summary, this study showed that SAE occurred at
higher rates among elderly patients of more advanced age.
SAE was also more likely to affect elderly sepsis patients
with higher serum sodium levels, while higher SOFA
scores, higher APACHE II scores, lower PLT, lower HCT,
underlying CHD, underlying stroke, and infections of the

blood or respiratory tract were all identified as possible
SAE-associated risk factors. In turn, elderly sepsis patients
with underlying COPD have a lower risk of developing
SAE. Elderly sepsis patients affected by SAE were found to
have a poorer prognosis than patients not affected by this
condition, with higher SOFA scores being independently
associated with mortality risk. Future studies will be
required to fully validate the prognostic value of the
indicators studied in the present article, extending our
findings to explore dynamic changes in SAE morbidity
and mortality among elderly populations.
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